High gas prices, expensive groceries, several wars overseas. These are some of the things keeping Americans up at night on this Halloween. What about the President? Here’s what he should be losing sleep over. www.youtube.com/watch?v=Pcsm...
The Things That Go Bump in the Night for Trump
YouTube video by MS NOW
www.youtube.com
October 31, 2026 at 10:23 PM
High gas prices, expensive groceries, several wars overseas. These are some of the things keeping Americans up at night on this Halloween. What about the President? Here’s what he should be losing sleep over. www.youtube.com/watch?v=Pcsm...
This #Movember the Alliance org is highlighting 8 ongoing clinical trials focused on advancing detection, treatment, and survivorship for men’s cancers, including prostate cancer. Learn more about how clinical research is shaping care: https://bit.ly/Movember26 #PCSM #movember
November 2, 2026 at 11:29 PM
This #Movember the Alliance org is highlighting 8 ongoing clinical trials focused on advancing detection, treatment, and survivorship for men’s cancers, including prostate cancer. Learn more about how clinical research is shaping care: https://bit.ly/Movember26 #PCSM #movember
High gas prices, expensive groceries, several wars overseas. These are some of the things keeping Americans up at night on this Halloween. What about the President? Here’s what he should be losing sleep over. www.youtube.com/watch?v=Pcsm...
The Things That Go Bump in the Night for Trump
YouTube video by MS NOW
www.youtube.com
October 31, 2026 at 10:23 PM
High gas prices, expensive groceries, several wars overseas. These are some of the things keeping Americans up at night on this Halloween. What about the President? Here’s what he should be losing sleep over. www.youtube.com/watch?v=Pcsm...
Updated ASTRO guidelines recommend moderate hypofractionation over conventional fractionation in localized prostate cancer across risk groups where definitive EBRT is elected #pcsm #oncology
Read more: www.onclive.com/view/astro-g...
Read more: www.onclive.com/view/astro-g...
October 28, 2026 at 6:00 PM
Updated ASTRO guidelines recommend moderate hypofractionation over conventional fractionation in localized prostate cancer across risk groups where definitive EBRT is elected #pcsm #oncology
Read more: www.onclive.com/view/astro-g...
Read more: www.onclive.com/view/astro-g...
Now out in #JCO! 👇
ENZARAD (ANZUP 1303): Phase 3 Trial of Enzalutamide with Androgen Deprivation Therapy and Radiation Therapy in High-Risk Localized or Locally Advanced Prostate Cancer.
Read the article. https://bit.ly/4zRcWMR
#ProstateCancer #pcsm
ENZARAD (ANZUP 1303): Phase 3 Trial of Enzalutamide with Androgen Deprivation Therapy and Radiation Therapy in High-Risk Localized or Locally Advanced Prostate Cancer.
Read the article. https://bit.ly/4zRcWMR
#ProstateCancer #pcsm
October 28, 2026 at 4:00 PM
Now out in #JCO! 👇
ENZARAD (ANZUP 1303): Phase 3 Trial of Enzalutamide with Androgen Deprivation Therapy and Radiation Therapy in High-Risk Localized or Locally Advanced Prostate Cancer.
Read the article. https://bit.ly/4zRcWMR
#ProstateCancer #pcsm
ENZARAD (ANZUP 1303): Phase 3 Trial of Enzalutamide with Androgen Deprivation Therapy and Radiation Therapy in High-Risk Localized or Locally Advanced Prostate Cancer.
Read the article. https://bit.ly/4zRcWMR
#ProstateCancer #pcsm
🚨BREAKING🚨: The @fda.gov has approved talazoparib in combination with enzalutamide for the treatment of adult patients with mAPM/S prostate cancer with HRR gene mutations, as detected by an FDA-authorized test. #pcsm #oncology
Full story ➡️: www.onclive.com/view/fda-app...
Full story ➡️: www.onclive.com/view/fda-app...
October 26, 2026 at 5:09 PM
🚨BREAKING🚨: The @fda.gov has approved talazoparib in combination with enzalutamide for the treatment of adult patients with mAPM/S prostate cancer with HRR gene mutations, as detected by an FDA-authorized test. #pcsm #oncology
Full story ➡️: www.onclive.com/view/fda-app...
Full story ➡️: www.onclive.com/view/fda-app...
Drs. Rana McKay of UC San Diego and Misha Beltran Dana-Farber co-lead @ALLIANCE_org A032102/PREDICT evaluating if genetic testing helps determine the best treatment regimen for men with metastatic prostate cancer. Learn more: https://bit.ly/Alliance-A032102 #PCsm #clinicaltrials
October 20, 2026 at 6:00 AM
Drs. Rana McKay of UC San Diego and Misha Beltran Dana-Farber co-lead @ALLIANCE_org A032102/PREDICT evaluating if genetic testing helps determine the best treatment regimen for men with metastatic prostate cancer. Learn more: https://bit.ly/Alliance-A032102 #PCsm #clinicaltrials
Get more from Percona ClusterSync for #MongoDB.
Learn to tune clone speed and replication with workers, batches, and connection pools: https://bit.ly/4yEcPEh
#DatabasePerformance #DataMigration #OpenSource
Learn to tune clone speed and replication with workers, batches, and connection pools: https://bit.ly/4yEcPEh
#DatabasePerformance #DataMigration #OpenSource
Tuning Percona ClusterSync for MongoDB Performance
Percona ClusterSync for MongoDB (PCSM) synchronizes data from a source MongoDB cluster (including Atlas) to a target MongoDB cluster in two stages. It first creates a consistent starting point and clo...
www.percona.com
October 13, 2026 at 8:48 PM
Get more from Percona ClusterSync for #MongoDB.
Learn to tune clone speed and replication with workers, batches, and connection pools: https://bit.ly/4yEcPEh
#DatabasePerformance #DataMigration #OpenSource
Learn to tune clone speed and replication with workers, batches, and connection pools: https://bit.ly/4yEcPEh
#DatabasePerformance #DataMigration #OpenSource
Percona ClusterSync for #MongoDB 1.0.0 is GA! 🎉
Automatic failover, sharding, and multi-target sync support near-zero-downtime migrations: https://bit.ly/3VDbSNY
#DataMigration #OpenSource #HighAvailability
Automatic failover, sharding, and multi-target sync support near-zero-downtime migrations: https://bit.ly/3VDbSNY
#DataMigration #OpenSource #HighAvailability
Percona ClusterSync for MongoDB 1.0.0 is Generally Available
On behalf of the entire product and engineering team, I’m pleased to announce that Percona ClusterSync for MongoDB (PCSM) 1.0.0 is now generally available with all its features inside. It is productio...
www.percona.com
October 13, 2026 at 3:15 PM
Percona ClusterSync for #MongoDB 1.0.0 is GA! 🎉
Automatic failover, sharding, and multi-target sync support near-zero-downtime migrations: https://bit.ly/3VDbSNY
#DataMigration #OpenSource #HighAvailability
Automatic failover, sharding, and multi-target sync support near-zero-downtime migrations: https://bit.ly/3VDbSNY
#DataMigration #OpenSource #HighAvailability
Last week’s #OncFive:
✅ Atezolizumab approved for CRC #crcsm #oncology
🎗️ Tucatinib approved for breast cancer #bcsm
🩸 IberDd hits PFS in myeloma #mmsm #hematology
🔵 Fast track for VIR-5500 in mCRPC #pcsm
🩸 Epcoritamab+R-CHOP hits PFS in DLBCL #lymsm
www.onclive.com/view/the-onc...
✅ Atezolizumab approved for CRC #crcsm #oncology
🎗️ Tucatinib approved for breast cancer #bcsm
🩸 IberDd hits PFS in myeloma #mmsm #hematology
🔵 Fast track for VIR-5500 in mCRPC #pcsm
🩸 Epcoritamab+R-CHOP hits PFS in DLBCL #lymsm
www.onclive.com/view/the-onc...
The OncFive: Top Oncology Articles for the Week of 10/4/2026 | OncLive
The FDA approved atezolizumab plus chemo for stage III colon cancer, cleared a tucatinib-based maintenance regimen for advanced breast cancer, and more.
www.onclive.com
October 11, 2026 at 12:27 PM
Last week’s #OncFive:
✅ Atezolizumab approved for CRC #crcsm #oncology
🎗️ Tucatinib approved for breast cancer #bcsm
🩸 IberDd hits PFS in myeloma #mmsm #hematology
🔵 Fast track for VIR-5500 in mCRPC #pcsm
🩸 Epcoritamab+R-CHOP hits PFS in DLBCL #lymsm
www.onclive.com/view/the-onc...
✅ Atezolizumab approved for CRC #crcsm #oncology
🎗️ Tucatinib approved for breast cancer #bcsm
🩸 IberDd hits PFS in myeloma #mmsm #hematology
🔵 Fast track for VIR-5500 in mCRPC #pcsm
🩸 Epcoritamab+R-CHOP hits PFS in DLBCL #lymsm
www.onclive.com/view/the-onc...
The @fda.gov granted fast track designation to the PSMA x CD3 T-cell engager VIR-5500 for the treatment of patients with late-line metastatic castration-resistant prostate cancer #pcsm #oncology
Read more: www.onclive.com/view/vir-550...
Read more: www.onclive.com/view/vir-550...
VIR-5500 Receives FDA Fast Track Designation in mCRPC | OncLive
The FDA granted fast track designation to the PSMA-targeted T-cell engager VIR-5500 for late-line metastatic castration-resistant prostate cancer.
www.onclive.com
October 8, 2026 at 5:22 PM
The @fda.gov granted fast track designation to the PSMA x CD3 T-cell engager VIR-5500 for the treatment of patients with late-line metastatic castration-resistant prostate cancer #pcsm #oncology
Read more: www.onclive.com/view/vir-550...
Read more: www.onclive.com/view/vir-550...
CumbriaMed Research Webinar "Understanding and Treating Mental Illness" - Thursday 22 October 12:30-13:30
💻 Location: Zoom (registration required)
👉 Register: brnw.ch...
Hosted by: PCSM Research Hub
Funded by: NIHR Imperial Biomedical Research Centre (BRC)
💻 Location: Zoom (registration required)
👉 Register: brnw.ch...
Hosted by: PCSM Research Hub
Funded by: NIHR Imperial Biomedical Research Centre (BRC)
October 7, 2026 at 8:53 AM
CumbriaMed Research Webinar "Understanding and Treating Mental Illness" - Thursday 22 October 12:30-13:30
💻 Location: Zoom (registration required)
👉 Register: brnw.ch...
Hosted by: PCSM Research Hub
Funded by: NIHR Imperial Biomedical Research Centre (BRC)
💻 Location: Zoom (registration required)
👉 Register: brnw.ch...
Hosted by: PCSM Research Hub
Funded by: NIHR Imperial Biomedical Research Centre (BRC)
The addition of the anti-CD105 antibody carotuximab to apalutamide improved PFS vs apalutamide alone in mCRPC #pcsm #oncology
Check out the data and how they are shaping the ongoing phase 2 study: www.onclive.com/view/carotux...
Check out the data and how they are shaping the ongoing phase 2 study: www.onclive.com/view/carotux...
Carotuximab Plus Apalutamide Improves PFS in mCRPC | OncLive
Carotuximab plus apalutamide demonstrated longer median progression-free survival than apalutamide alone in an interim phase 2 analysis in mCRPC.
www.onclive.com
October 6, 2026 at 6:21 PM
The addition of the anti-CD105 antibody carotuximab to apalutamide improved PFS vs apalutamide alone in mCRPC #pcsm #oncology
Check out the data and how they are shaping the ongoing phase 2 study: www.onclive.com/view/carotux...
Check out the data and how they are shaping the ongoing phase 2 study: www.onclive.com/view/carotux...
Now enrolling! Dr. Deepak Kilari from @MedicalCollege is now enrolling @ALLIANCE-org A032302, the ASPIRE trial to see if adding chemo to hormone therapy improves survival in men with metastatic #prostatecancer. To learn more, visit http://bit.ly/AllianceA032302. #clinicaltrials #PCSM
October 6, 2026 at 10:00 AM
Now enrolling! Dr. Deepak Kilari from @MedicalCollege is now enrolling @ALLIANCE-org A032302, the ASPIRE trial to see if adding chemo to hormone therapy improves survival in men with metastatic #prostatecancer. To learn more, visit http://bit.ly/AllianceA032302. #clinicaltrials #PCSM
The addition of the ATR inhibitor berzosertib to carboplatin failed to boost responses vs carboplatin with/without docetaxel in heavily pretreated mCRPC #pcsm #oncology
Dive into the phase 2 data here: www.onclive.com/view/berzose...
Dive into the phase 2 data here: www.onclive.com/view/berzose...
Berzosertib Plus Carboplatin Fails to Improve Responses in Pretreated mCRPC | OncLive
A randomized phase 2 trial of berzosertib plus carboplatin in pretreated mCRPC stopped for futility amid fewer responses and more high-grade toxicity than the control arm.
www.onclive.com
October 5, 2026 at 2:29 PM
The addition of the ATR inhibitor berzosertib to carboplatin failed to boost responses vs carboplatin with/without docetaxel in heavily pretreated mCRPC #pcsm #oncology
Dive into the phase 2 data here: www.onclive.com/view/berzose...
Dive into the phase 2 data here: www.onclive.com/view/berzose...
Phase 2 and 3 data showed aglatimagene besadenovec plus EBRT was associated with improved prostate cancer–specific disease-free survival and evidence of sustained immune activity in intermediate-risk localized prostate cancer #pcsm #oncology
www.onclive.com/view/aglatim...
www.onclive.com/view/aglatim...
Aglatimagene Besadenovec Shows Durable Immune Activity in Intermediate-Risk Localized Prostate Cancer | OncLive
Aglatimagene besadenovec plus EBRT was linked to a 41% lower risk of prostate cancer recurrence or death, alongside durable immune activity.
www.onclive.com
October 2, 2026 at 2:00 PM
Phase 2 and 3 data showed aglatimagene besadenovec plus EBRT was associated with improved prostate cancer–specific disease-free survival and evidence of sustained immune activity in intermediate-risk localized prostate cancer #pcsm #oncology
www.onclive.com/view/aglatim...
www.onclive.com/view/aglatim...
“In the hormone therapy subgroup, the CC genotype was significantly associated with increased PCSM among patients with metastatic (HR=6.79, 95% CI: 2.03-17.2, P<0.001) and advanced (HR=3.29, 95% CI: 1.10-11.7, P=0.03) disease.” aacrjournals.org/cancerres/ar...
Abstract 3594: Adrenal-permissive HSD3B1 genotype and prostate cancer-specific mortality among patients: Insights from the multiethnic cohort Study
AbstractBackground:. The HSD3B1 gene encodes an androgen synthesis enzyme critical for prostate cancer (PCa) progression. The CC genotype of a common missense variant in HSD3B1 (rs1047303) is consider...
aacrjournals.org
September 30, 2026 at 11:54 PM
“In the hormone therapy subgroup, the CC genotype was significantly associated with increased PCSM among patients with metastatic (HR=6.79, 95% CI: 2.03-17.2, P<0.001) and advanced (HR=3.29, 95% CI: 1.10-11.7, P=0.03) disease.” aacrjournals.org/cancerres/ar...
🔎 What happens after a cancer screening result comes back positive, but cancer isn’t found?
Jason Hafron, MD, of @oaklandu.bsky.social, discusses the often-overlooked burden of false positives and the need for more precise screening. #pcsm #oncology
Read more: www.onclive.com/view/calcula...
Jason Hafron, MD, of @oaklandu.bsky.social, discusses the often-overlooked burden of false positives and the need for more precise screening. #pcsm #oncology
Read more: www.onclive.com/view/calcula...
Calculating the Real Cost of False Positive Findings in Cancer Screening | OncLive
Jason Hafron, MD, discusses the emotional, clinical, and financial burden of false positive cancer screening results and improved risk stratification.
www.onclive.com
September 29, 2026 at 12:01 AM
🔎 What happens after a cancer screening result comes back positive, but cancer isn’t found?
Jason Hafron, MD, of @oaklandu.bsky.social, discusses the often-overlooked burden of false positives and the need for more precise screening. #pcsm #oncology
Read more: www.onclive.com/view/calcula...
Jason Hafron, MD, of @oaklandu.bsky.social, discusses the often-overlooked burden of false positives and the need for more precise screening. #pcsm #oncology
Read more: www.onclive.com/view/calcula...
Just over a week ago, we welcomed our newest cohort to PCSM💙
From making new connections to taking their first steps towards a career in medicine, Welcome Week was full of exciting and memorable experiences.
#PCSM #FutureDoctors #WelcomeWeek #MedicalSchoolLife #StudentExperience #CumbriaMedicine
From making new connections to taking their first steps towards a career in medicine, Welcome Week was full of exciting and memorable experiences.
#PCSM #FutureDoctors #WelcomeWeek #MedicalSchoolLife #StudentExperience #CumbriaMedicine
September 18, 2026 at 12:40 PM
Just over a week ago, we welcomed our newest cohort to PCSM💙
From making new connections to taking their first steps towards a career in medicine, Welcome Week was full of exciting and memorable experiences.
#PCSM #FutureDoctors #WelcomeWeek #MedicalSchoolLife #StudentExperience #CumbriaMedicine
From making new connections to taking their first steps towards a career in medicine, Welcome Week was full of exciting and memorable experiences.
#PCSM #FutureDoctors #WelcomeWeek #MedicalSchoolLife #StudentExperience #CumbriaMedicine
Drs. Rana McKay of UC San Diego and Misha Meltran Dana-Farber co-lead Alliance A032102/PREDICT evaluating if genetic testing helps determine the best treatment regimen for men with metastatic prostate cancer. Learn more: https://bit.ly/Alliance-A032102 #PCsm
September 18, 2026 at 10:00 AM
Drs. Rana McKay of UC San Diego and Misha Meltran Dana-Farber co-lead Alliance A032102/PREDICT evaluating if genetic testing helps determine the best treatment regimen for men with metastatic prostate cancer. Learn more: https://bit.ly/Alliance-A032102 #PCsm
Not all metastatic hormone-sensitive prostate cancers behave the same. New research shows baseline ctDNA tumor fraction before ADT initiation may help identify patients at higher risk for worse outcomes.
Read the article. https://bit.ly/4cucn2r
#ProstateCancer #pcsm
Read the article. https://bit.ly/4cucn2r
#ProstateCancer #pcsm
September 10, 2026 at 4:00 PM
Not all metastatic hormone-sensitive prostate cancers behave the same. New research shows baseline ctDNA tumor fraction before ADT initiation may help identify patients at higher risk for worse outcomes.
Read the article. https://bit.ly/4cucn2r
#ProstateCancer #pcsm
Read the article. https://bit.ly/4cucn2r
#ProstateCancer #pcsm
Courage
YouTube video by The Whitest Boy Alive - Topic
music.youtube.com
September 9, 2026 at 7:05 AM
♥️ SÃO LUIS - MA ♥️
A conhecida como A Ilha do Amor e Jamaica Brasileira.
Hoje, 08 de Setembro, a minha Terra amada completa 414 anos.
Meu Nordeste, meu Maranhão. Eu te Amo!
O vídeo é de 2021 mas já dá para vocês passearem pela minha amassada São Luis!
Venham comigo! 🥰
m.youtube.com/watch?v=pcsm...
A conhecida como A Ilha do Amor e Jamaica Brasileira.
Hoje, 08 de Setembro, a minha Terra amada completa 414 anos.
Meu Nordeste, meu Maranhão. Eu te Amo!
O vídeo é de 2021 mas já dá para vocês passearem pela minha amassada São Luis!
Venham comigo! 🥰
m.youtube.com/watch?v=pcsm...
SÃO LUÍS VISTA DE CIMA - 4K (2021)
YouTube video by PARTIUBR
m.youtube.com
September 8, 2026 at 8:30 PM
♥️ SÃO LUIS - MA ♥️
A conhecida como A Ilha do Amor e Jamaica Brasileira.
Hoje, 08 de Setembro, a minha Terra amada completa 414 anos.
Meu Nordeste, meu Maranhão. Eu te Amo!
O vídeo é de 2021 mas já dá para vocês passearem pela minha amassada São Luis!
Venham comigo! 🥰
m.youtube.com/watch?v=pcsm...
A conhecida como A Ilha do Amor e Jamaica Brasileira.
Hoje, 08 de Setembro, a minha Terra amada completa 414 anos.
Meu Nordeste, meu Maranhão. Eu te Amo!
O vídeo é de 2021 mas já dá para vocês passearem pela minha amassada São Luis!
Venham comigo! 🥰
m.youtube.com/watch?v=pcsm...